Lactate dehydrogenase as a prognostic biomarker in patients with hormone receptor-positive metastatic breast cancer treated with palbociclib: An exploratory cohort study. (October 2020) - Pelizzari, G.; Bertoli, E.; Basile, D.; Giavarra, M.; Gerratana, L.; Bartoletti, M.; Lisanti, C.; Corvaja, C.; Vitale, M.G.; Michelotti, A.; Avoledo, D.; Ros, L.Da; et al.